Howard Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Howard Wealth Management's XBI Position: Q3 2026 in Review
Howard Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 1,318 shares worth $208K. The position accounts for 0.08% of the portfolio, ranked #146.
Howard Wealth Management first reported a position in XBI in Q4 2019 and has held it in 10 quarters since. The position peaked at $348K in Q4 2020. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Howard Wealth Management held 1,318 shares of State Street SPDR S&P Biotech ETF worth $208K as of Q3 2026.
- Howard Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.08% of Howard Wealth Management's portfolio in Q3 2026, its #146 holding.
- Howard Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 10 quarters since.
- Howard Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $348K in Q4 2020.
- 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Howard Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.